ClinicalTrials.gg
RecruitingNCT06864065EmoBEDUpdated Jul 22, 2025

Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder

An interventional study of Emotion regulation task (fNIRS recording during the emotional regulation task) in Binge-Eating Disorder, Emotional Eating and Healthy Volunteers, sponsored by Centre Hospitalier Universitaire de Besancon. Recruiting at 3 sites in France. Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-22.

Sponsored by Centre Hospitalier Universitaire de Besancon · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Non-randomized
Ages
18 Years to 60 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Binge-Eating Disorder with a site in France — 3 open to participants now, 4 under way, none of them phase 3. Binge-Eating Disorder · France.

Planned enrollment
5th of 10
80 · median 74
Started
2025
with 1 other
No phase
9 of 15
2 open now
Registered
14th of 15
by date
Lead sponsor
1 of 15
Centre Hospitalier Universitaire de Besancon

Among the 15 studies in Binge-Eating Disorder with a site in France, this one is the 5th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2025, is one of 9 with no phase, and was the 14th registered.

Binge-Eating Disorder

233 studies on the registry are indexed under Binge-Eating Disorder; 50 are open to participants now.

Browse Binge-Eating Disorder studies →

Open to participants now

3 of the 15 studies in Binge-Eating Disorder with a site in France are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 33 Binge-Eating Disorder studies recruiting now, 8 (24%) set no upper age limit and 22 (67%) stop at 75 or younger; 10 take children under 18; 4 take healthy volunteers.

This study: 18 Years to 60 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Binge-Eating Disorder with a site in France, or all of them as a file.
02

Study summary

The goal of this exploratory, interventional, multicentre study is to compare the prefrontal activity during a negative emotion regulation task in women with Binge-Eating Disorder (BED) and healthy women with and without Emotional Eating (EE).

The aim of this study is to compare the prefrontal processing of cognitive control of emotions between BED and EE and to compare the emotional processing and emotional experience between BED and EE.

The study will thus compare four experimental groups: patients with BED, BMI-matched healthy volunteers with EE, BMI-matched healthy volunteers, and healthy volunteers of normal weight without BED.

Participants will perform a down-regulation task of negative emotions elicited by negative pictures. During this task, their cerebral activity will be recorded using functional near-infrared spectroscopy (fNIRS), as well as their autonomous activity (skin conductance, pulse rate, respiration rate).

03

Conditions studied

  • Binge-Eating Disorder
  • Emotional Eating
  • Healthy Volunteers

Keywords

  • Binge-Eating Disorder
  • Emotion regulation
  • fNIRS
  • Prefrontal cortex
  • Eating disorder
  • Emotional Eating
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Women between 18 and 60 years old (including 60)
  • Right-handed.
  • For patients only : diagnosed with Binge Eating Desordors according to DSM criteria.
  • Membership of a French social security scheme or beneficiary of such a scheme.
  • Non-opposition of the subject to participate in the study.

Non inclusion Criteria:

Healthy volunteers only :

  • Suffering from an eating disorder or any other psychiatric disorder.
  • History of bariatric surgery.

All subjects (healthy volunteers and patients) :

  • Rare obesity (genetic or syndromic).
  • Specific addictions (substances or behaviors).
  • Neurological disorders and/or history of stroke or head trauma.
  • Presence of lesions, wounds or dermatitis at the sites where the recording devices are applied.
  • Any serious acute or chronic illness other than the pathology under study, or any treatment likely to interfere with the evaluation of the parameter under study.
  • Inability to follow protocol requirements.
  • Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator.
  • Subject unable to speak French and/or unable to read.
  • Pregnant or breast-feeding women.
  • Persons deprived of their liberty by judicial or administrative decision; persons under compulsory psychiatric care; persons admitted to a health or social institution for purposes other than research.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Patients with binge eating desorders

    Patients with binge eating desorders

    Behavioral: Emotion regulation task (fNIRS recording during the emotional regulation task)

  • Experimental
    healthy volunteers with a low score at the emotion eating scale compare to median

    group matched with patients for age and body mass index

    Behavioral: Emotion regulation task (fNIRS recording during the emotional regulation task)

  • Experimental
    healthy volunteers with a high score at the emotion eating scale compare to median

    group matched with patients for age and body mass index

    Behavioral: Emotion regulation task (fNIRS recording during the emotional regulation task)

  • Experimental
    healthy volunteers normo-weight group with a low score at the emotion eating scale compare to median

    healthy volunteers with normo-weight group matched with patients only in age but not in Body Mass Iindex with an Emotional Eating score below the median

    Behavioral: Emotion regulation task (fNIRS recording during the emotional regulation task)

Interventions

  • BehavioralEmotion regulation task (fNIRS recording during the emotional regulation task)

    No drugs were used in this study. All participants perform an emotion regulation task. More precisely, they have to down regulate negative emotions elicited by negative pictures using a cognitive reaprasal strategy. To this end, they have to change the meaning of the picture they are watching in order to decrease motional intensity.

06

What researchers measure

Primary outcomes

  1. Measurement of prefrontal cortex activity using functional near-infrared imaging (fNIRS).

    The fNIRS signal represents the concentration of oxyhemoglobin and deoxyhemoglobin over time. It provides information about the local oxygen demand of the brain and therefore its activity. It is these concentrations during the regulatory task that are used as the primary outcome measure.

    Time frame: Day 1 during the viewing of images with negative valence

Secondary outcomes

  1. Psychophysiological measurements: electrodermal activity

    Skin conductance measures are recorded These provide information on the autonomic nervous system (sympathetic and parasympathetic) and thus on emotional processing and arousal.

    Time frame: Day 1 during the viewing of images with negative valence

  2. Psychophysiological measurements: electrocardiogram

    Electrocardiogram measures are recorded These provide information on the autonomic nervous system (sympathetic and parasympathetic) and thus on emotional processing and arousal.

    Time frame: Day 1 during the viewing of images with negative valence

  3. Psychophysiological measurements: respiratory rate

    Respiratory rate is recorded These provide information on the autonomic nervous system (sympathetic and parasympathetic) and thus on emotional processing and arousal.

    Time frame: Day 1 during the viewing of images with negative valence

07

Study locations

2 of 3 sites recruiting
08

References and documents

Publications

  • Parker MN, Burton Murray H, Piers AD, Muratore A, Lowe MR, Manasse SM, Ayaz H, Juarascio AS. Prefrontal cortex activation by binge-eating status in individuals with obesity while attempting to reappraise responses to food using functional near infrared spectroscopy. Eat Weight Disord. 2023 Mar 30;28(1):34. doi: 10.1007/s40519-023-01558-z. PubMed 36995567 ↗
  • Dingemans A, Danner U, Parks M. Emotion Regulation in Binge Eating Disorder: A Review. Nutrients. 2017 Nov 22;9(11):1274. doi: 10.3390/nu9111274. PubMed 29165348 ↗
  • Arexis M, Feron G, Brindisi MC, Billot PE, Chambaron S. A scoping review of emotion regulation and inhibition in emotional eating and binge-eating disorder: what about a continuum? J Eat Disord. 2023 Nov 10;11(1):197. doi: 10.1186/s40337-023-00916-7. PubMed 37950264 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Oct 2026, 16 months after the start.

Of 81 non-industry interventional studies with no phase under Binge-Eating Disorder, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 53. This study's planned 16 months is below that.

Counting every sponsor, half of 86 studies reached it within 25 months; a quarter within 16 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 11, 2025
First posted
Mar 7, 2025
StartActual
Jun 24, 2025
Primary completionEst.
Oct 30, 2026
CompletionEst.
Oct 30, 2026
Last update
Jul 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06864065
Collaborators
INSERM UMR 1322 LINC
Responsible party
Sponsor
First posted
Mar 7, 2025
Start date
Jun 24, 2025
Primary completion
Oct 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Jul 22, 2025

Study contacts

BILLOT Pierre-Edouard, PhD
Contact
pierre-edouard.billot@univ-fcomte.fr
+33363082216
POZET Astrid
Contact
apozet@chu-besancon.fr
+33381218988
AMSALLEM Anne-Cécile, MD
study director · CHU de Besançon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion